Wikio - Ophtalmology

Ophthalmology Review Criteria Guidelines Provides Detailed Review Criteria for In- and Outpatient Tests and Procedures (Business Wire)

Fri, 16 May 2008 08:44:00 GMT

PermalinkOphthalmology Review Criteria Guidelines Provides Detailed Review Criteria for In- and Outpatient Tests and Procedures DUBLIN, Ireland--()--Research and Markets () has announced the addition of "Ophthalmology Review Criteria Guidelines" to their offering. Detailed review criteria for in- and outpatient tests and procedures. Resources include references, list of procedures performed...

Source : Business Wire (subscribe)

Explore : Health

High blood pressure, high cholesterol may be associated with retinal vascular disease (Physorg)

Mon, 12 May 2008 21:19:11 GMT

High blood pressure and high cholesterol levels appear to be risk factors for retinal vein occlusion, a condition that causes vision loss, according to a report in the May issue of Archives of Ophthalmology.

Source : Physorg (subscribe)

Explore : Diseases, Health, Sciences

Glaucoma Patients With Poor Health Literacy May Have Greater Disease Progression (Medical News Today)

Mon, 12 May 2008 20:00:00 GMT

Glaucoma patients in urban areas who have poor health literacy appear to miss more appointments and to have worse disease understanding and greater disease progression than patients with adequate health literacy, according to a report in the May issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

Source : Medical News Today (subscribe)

Explore : Diseases, Health

High Blood Pressure, High Cholesterol May Be Associated With Retinal Vascular Disease (Medical News Today)

Mon, 12 May 2008 20:00:00 GMT

Source : Medical News Today (subscribe)

Explore : Diseases, Health

Margolis Takes on ARVO Presidency (Newswise)

Mon, 12 May 2008 13:00:00 GMT

Todd Margolis, MD, PhD (University of California-San Francisco) is the new president of the Association for Research in Vision and Ophthalmology, taking over from Martine Jager, MD, PhD (Leiden University, The Netherlands), whose one-year term ended in April. Donald Hood, PhD (Columbia University) and Barry Winkler, PhD (Oakland University) will serve as vice presidents. Nicholas Delamere, PhD...

Source : Newswise (subscribe)

Explore : California, Cities and Towns, Columbia University, Health, San Francisco

Protecting Yourself Against Inflation (GuruFocus Updates)

Fri, 09 May 2008 16:17:28 GMT

Not long ago, Allen M. Demby, M.D., of Wyckoff, N.J., retired from practicing ophthalmology and became a registered investment adviser. So, I asked him, what financial mistakes has he seen many of his new clients making?

Source : GuruFocus Updates (subscribe)

Explore : Health

Diabetes Seems to Heighten Glaucoma Risk (Medical,Health News and Articles)

Wed, 07 May 2008 18:00:09 GMT

May 2 — While diabetes has long been associated with the potentially sight-stealing disease diabetic retinopathy, it appears that another serious eye disease — glaucoma — may also be a complication of the metabolic disorder. A recent study in the journal Ophthalmology found that women with diabetes have about a 70 percent increased risk of [...]

Source : Medical,Health News and Articles (subscribe)

Explore : Health

Subspecialist Shortages and the EMR (Dr. Wes)

wes@medtees.com (Westby G. Fisher, MD) — Mon, 05 May 2008 12:00:24 GMT

The growing pay gap of non-procedurally-based subspecialties is threatening acute shortages of physicians in those fields: A discipline built on spending time with patients to gather clues for a diagnosis, neuro-ophthalmology could become another casualty of a medical payment system that favors high-tech procedures over low-tech exams. The median income of a neuro-ophthalmologist at a teaching...

Source : Dr. Wes (subscribe)

Explore : Health

News From The May 2008 Issue Of Ophthalmology (Medical News Today)

Sun, 04 May 2008 18:00:00 GMT

Three studies in the May 2008 issue of Ophthalmology, the journal of the American Academy of Ophthalmology, shed new light on important eye health issues: the role of antioxidant supplements, the relationship of visual acuity and mortality, and the complex causes of glaucoma.

Source : Medical News Today (subscribe)

Explore : Health

Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology Meeting (Red Orbit )

Thu, 01 May 2008 14:01:06 GMT

JAMAICA PLAIN, Mass., May 1 /PRNewswire/ -- Paloma Pharmaceuticals, Inc.

Source : Red Orbit (subscribe)

Explore : Caribbean, Health, Jamaica

New Findings on Vitamin E and Cataracts in Women, Good Vision and Longer Life, and a Possible Cause of Glaucoma (Business Wire)

Thu, 01 May 2008 13:00:00 GMT

SAN FRANCISCO--(BUSINESS WIRE)--Three studies in the May 2008 issue of Ophthalmology, the journal of the American Academy of Ophthalmology, shed new light on important eye health

Source : Business Wire (subscribe)

Explore : Health, Health Industries

May 2008 Ophthalmology highlights (Eurekalert)

Thu, 01 May 2008 05:00:00 GMT

Research highlights from the May 2008 issue of Ophthalmology include: New findings on vitamin E and cataracts in women; Good vision and longer life; and a Possible cause of glaucoma.

Source : Eurekalert (subscribe)

Explore : Health, Sciences

Dr. Gabriel Sosne Presents TB4 Anti-inflammation Data at ARVO (The Earth Times Online Newspaper)

Tue, 29 Apr 2008 13:24:49 GMT

BETHESDA, Md. - REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN) (www.regenerx.com) announced today that Dr. Gabriel Sosne, Assistant Professor of Ophthalmology at Wayne State University School of Medicine and the Kresge Eye Institute in Detroit, MI,

Source : The Earth Times Online Newspaper (subscribe)

Explore : Cities and Towns, Detroit, Health

Soft Contact Lenses Do Not Increase Myopia Progression In Children, Study Shows (Medical News Today)

Tue, 29 Apr 2008 07:00:00 GMT

Soft contact lens wear does not accelerate the development of nearsightedness in children, a new study shows. Findings from the three year study, the largest randomized trial of its kind, were presented at the annual meeting of The Association for Research in Vision and Ophthalmology (ARVO).

Source : Medical News Today (subscribe)

Explore : Health

Academy Testifies At FDA Meeting On Lasik Outcomes And Satisfaction (Medical News Today)

Mon, 28 Apr 2008 10:00:00 GMT

Physicians representing the American Academy of Ophthalmology (Academy) and the International Society of Refractive Surgery (ISRS) spoke to a meeting of the FDA's Ophthalmic Devices Panel about the long track record of safety and effectiveness for LASIK eye surgery.

Source : Medical News Today (subscribe)

Explore : Health

Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) (The Earth Times Online Newspaper)

Sun, 27 Apr 2008 15:00:42 GMT

... oral poster presentation at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO). Dr. Grant reported patients who received Xibrom in addition to Lucentis (the Combination Group) required 1.6 +/- 0.69 injections of Lucentis during the six-month study period, while patients who received Lucentis only received 4.5 +/- 0.41 injections (p=0.0002). The original...

Source : The Earth Times Online Newspaper (subscribe)

Explore : Health

Inspire Announces Poster Presentations at 2008 Association for Research in Vision and Ophthalmology Annual Meeting (The Earth Times Online Newspaper)

Fri, 25 Apr 2008 11:31:48 GMT

DURHAM, N.C. - Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that Inspire scientists and collaborators will present information in four poster presentations at the 2008 Association for Research in Vision and Ophthalmology (ARVO) annual meeting April 27 - May 1, 2008 in Ft.

Source : The Earth Times Online Newspaper (subscribe)

Explore : Cities and Towns, Durham, Health, NASDAQ

Inspire Announces Poster Presentations at 2008 Association for Research in Vision and Ophthalmology Annual Meeting (Business Wire)

Fri, 25 Apr 2008 11:30:00 GMT

DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that Inspire scientists and collaborators will present information in four poster presentations at

Source : Business Wire (subscribe)

Explore : Cities and Towns, Durham, Health, Health Industries, NASDAQ

ESBATech Initiates Phase I Development of Ophthalmic Drug (Red Orbit )

Fri, 25 Apr 2008 11:00:43 GMT

ESBATech, a developer of antibody fragment therapeutics, has initiated a Phase I clinical development of the company's lead product development candidate, ESBA105, in ophthalmology.

Source : Red Orbit (subscribe)

Explore : Health

ESBATech's Lead Antibody Fragment Enters Clinical Development For Ophthalmic Indications (Medical News Today)

Fri, 25 Apr 2008 07:00:00 GMT

ESBATech AG, a leading developer of antibody fragment therapeutics, announced the initiation of Phase I clinical development of the company's lead product development candidate, ESBA105, in ophthalmology. This Phase I study is designed to evaluate the safety, tolerability and pharmacokinetic profile of ESBA105, when delivered topically via eye drops in healthy volunteers.

Source : Medical News Today (subscribe)

Explore : Health